"Specializing in conditions that affect the back of the eye: Macular Degeneration, Diabetic Retinopathy, Retinal Vascular Disease, Retinal Tears and Detachments."

During the past decade, Central Florida Retina conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Central Florida Retina" are "Choroidal Neovascularization" (1 trials), "Diabetic Macular Edema" (1 trials), "Macular Degeneration" (1 trials) and "Retinal Detachment" (1 trials). Many other conditions were trialed in "Central Florida Retina" in a lesser frequency.

Most popular intervention types in "Central Florida Retina" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab + Deferred Aflibercept Group" (1 trials), "Faricimab" (1 trials), "Ranibizumab" (1 trials), "Sham Procedure" (1 trials) and "denufosol tetrasodium (INS37217) Intravitreal Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Florida Retina" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Central Florida Retina". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Central Florida Retina, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Central Florida Retina, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".